» Articles » PMID: 39192862

Diabetes and Susceptibility to COVID-19: Risk Factors and Preventive and Therapeutic Strategies

Overview
Specialty Endocrinology
Date 2024 Aug 28
PMID 39192862
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by a novel human coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Diabetes is a well-known risk factor for infectious diseases with high prevalence and increased severity. Here, we elucidated the possible factors for the increased vulnerability of diabetic patients to SARS-CoV-2 infection and the more severe COVID-19 illness. The worsened prognosis of patients with both COVID-19 and diabetes may be attributable to host receptor angiotensin-converting enzyme 2-assisted viral uptake. Moreover, insulin resistance is often associated with impaired mucosal and skin barrier integrity, resulting in mic-robiota dysbiosis, which increases susceptibility to viral infections. It may also be associated with higher levels of pro-inflammatory cytokines resulting from an impaired immune system in diabetics, inducing a cytokine storm and excessive inflammation. This review describes diabetes mellitus and its complications, explains the risk factors, such as disease characteristics and patient lifestyle, which may contribute to the high susceptibility of diabetic patients to COVID-19, and discusses preventive and therapeutic strategies for COVID-19-positive diabetic patients.

Citing Articles

Role of nutrition in diabetes mellitus and infections.

Yu X, Zhou L, Huang X, Li X, Wang M, Yang J World J Clin Cases. 2025; 13(3):94389.

PMID: 39866654 PMC: 11577521. DOI: 10.12998/wjcc.v13.i3.94389.


Interactions of SARS-CoV-2 with Human Target Cells-A Metabolic View.

Eisenreich W, Leberfing J, Rudel T, Heesemann J, Goebel W Int J Mol Sci. 2024; 25(18).

PMID: 39337465 PMC: 11432161. DOI: 10.3390/ijms25189977.

References
1.
Hamer M, Kivimaki M, Gale C, Batty G . Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020; 87:184-187. PMC: 7245300. DOI: 10.1016/j.bbi.2020.05.059. View

2.
Tareq A, Emran T, Dhama K, Dhawan M, Tallei T . Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic. Hum Vaccin Immunother. 2021; 17(11):4126-4127. PMC: 8425453. DOI: 10.1080/21645515.2021.1963601. View

3.
Clarke N, Turner A . Angiotensin-converting enzyme 2: the first decade. Int J Hypertens. 2011; 2012:307315. PMC: 3216391. DOI: 10.1155/2012/307315. View

4.
Suk K, Kim S, Kim Y, Kim K, Chang I, Yagita H . IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol. 2001; 166(7):4481-9. DOI: 10.4049/jimmunol.166.7.4481. View

5.
Zhou X, Shen X, Johnson J, Spakowicz D, Agnello M, Zhou W . Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease. Cell Host Microbe. 2024; 32(4):506-526.e9. PMC: 11022754. DOI: 10.1016/j.chom.2024.02.012. View